Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy.

  • Authors:
    • J Fueyo
    • C Gomez-Manzano
    • V K Puduvalli
    • P Martin-Duque
    • R Perez-Soler
    • V A Levin
    • W K Yung
    • A P Kyritsis
  • View Affiliations

  • Published online on: March 1, 1998     https://doi.org/10.3892/ijo.12.3.665
  • Pages: 665-674
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Malignant gliomas are highly resistant to chemotherapy, in part because of the blood-brain barrier, which restricts the delivery of chemotherapy to certain areas of tumor and their cellular heterogeneity, which leads to the selection and propagation of resistant clones. However, the molecular basis of the drug resistance is poorly understood. In this study, we examined the effect of the cell cycle-inhibitory protein p16 on the chemosensitivity of human glioma cells. Treatment of the p16-null glioma cells, U-251 MG and D-54 MG, with paclitaxel and topotecan, resulted in cell death within 4 days. However, overexpression of exogenous wild-type p16 protein using an adenovirus vector resulted in G1 arrest of glioma cells and resistance to the anticancer effect of paclitaxel or topotecan. Specifically, the p16-expressing cells showed a 30-fold increase in the ID50 of topotecan and a more than 40-fold increase in the ID50 of paclitaxel. These observations indicate that overexpression of molecules that control cell-cycle progression may be partially responsible for causing the resistance of glioma cells to cytocidal drugs.

Related Articles

Journal Cover

Mar 1998
Volume 12 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Fueyo J, Gomez-Manzano C, Puduvalli V, Martin-Duque P, Perez-Soler R, Levin V, Yung W and Kyritsis A: Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy.. Int J Oncol 12: 665-674, 1998.
APA
Fueyo, J., Gomez-Manzano, C., Puduvalli, V., Martin-Duque, P., Perez-Soler, R., Levin, V. ... Kyritsis, A. (1998). Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy.. International Journal of Oncology, 12, 665-674. https://doi.org/10.3892/ijo.12.3.665
MLA
Fueyo, J., Gomez-Manzano, C., Puduvalli, V., Martin-Duque, P., Perez-Soler, R., Levin, V., Yung, W., Kyritsis, A."Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy.". International Journal of Oncology 12.3 (1998): 665-674.
Chicago
Fueyo, J., Gomez-Manzano, C., Puduvalli, V., Martin-Duque, P., Perez-Soler, R., Levin, V., Yung, W., Kyritsis, A."Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy.". International Journal of Oncology 12, no. 3 (1998): 665-674. https://doi.org/10.3892/ijo.12.3.665